Article Text

Download PDFPDF
Hypermetabolism in motor neurone disease is associated with a greater functional decline but not weight loss
  1. Zara A Ioannides1,2,3,
  2. Shyuan T Ngo2,4,5,
  3. Robert D Henderson1,3,
  4. Pamela A McCombe1,2,3,
  5. Frederik J Steyn2,6
  1. 1Neurology, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia
  2. 2Centre for Clinical Research (CCR), University of Queensland, Brisbane, QLD, Australia
  3. 3School of Medicine, University of Queensland, Brisbane, QLD, Australia
  4. 4School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia
  5. 5Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia
  6. 6Wesley Medical Research, The Wesley Hospital, Brisbane, QLD, Australia


Objectives Motor Neurone Disease (MND) is fatal neurological disease. Hypermetabolism (increased resting energy expenditure (REE)) and loss of body weight occur in MND. We aimed to determine whether hypermetabolism correlates with disease severity and weight loss.

Methods Patients (n=44) and control participants (n=45) presented at the MND clinic at the CCR following an overnight fast. Body composition was assessed using air displacement plethysmography (BodPod; COSMED). REE was assessed by indirect calorimetry (Quark RMR, COSMED) and a metabolic index (MI;% change in measured REE versus predicted REE) determined. Hypermetabolism was defined as MI>120%. Disease severity was assessed using the Amyotrophic Lateral Sclerosis Functional Rating scale (ALSFRS-R) and respiratory function tests (RFTs). A subset of MND patients (n=30) returned for a repeat assessment ~4 months later.

Results Hypermetabolism was more prevalent in MND (41%) when compared with control (18%) participants. In longitudinal analyses, hypermetabolism was not associated with a change in RFTs (including forced vital capacity, p=0.91 and sniff nasal pressure, p=0.40), loss of body weight (p=0.79) or a reduction in% fat mass (p=0.78). Strikingly, hypermetabolic individuals experienced a greater decline in ALSFRS-R over the sampling interval (p<0.01).

Conclusions We confirm a greater prevalence of hypermetabolism in MND when compared with matched controls. Hypermetabolism in MND patients is associated with a greater functional decline but not a change in RFTs or weight loss. While challenging the notions that hypermetabolism is a consequence of respiratory dysfunction and that it contributes to weight loss, our emerging insights suggest that hypermetabolism contributes to disease progression. Thus, hypermetabolism could have major implications for quality of life and possibly disease survival. Ongoing studies aim to clarify the cause for and consequence of hypermetabolism in MND.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.